Ionsys is the first needle-free, patient-controlled fentanyl delivery system designed for postoperative pain management.
Ionsys’ efficacy was examined in three placebo-controlled trials. The device’s safety was examined in an additional three placebo-controlled trials and four active-controlled randomized trials.
Ionsys is expected to become available in the United States later this year, according to the report.
More articles on anesthesia:
NAPA division launches pain management awareness campaign
Male & female anesthesiologists: 8 statistics on compensation, satisfaction
4 things to know about computer-assisted sedation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.